Type 1 Diabetes Clinical Trials in Miami, Florida
10 recruitingMiami, Florida
Showing 1–10 of 10 trials
Recruiting
Registry for Stage 2 Type 1 Diabetes
Type 1 Diabetes
Sanofi200 enrolled37 locationsNCT06481904
Recruiting
Phase 2
FrexalimAB in Preservation of Endogenous insULIN Secretion Compared to Placebo in adUlts and Adolescents on Top of inSulin Therapy (FABULINUS)
Type 1 Diabetes Mellitus
Sanofi192 enrolled80 locationsNCT06111586
Recruiting
Phase 1
A Study of GNTI-122 in Adults Recently Diagnosed With T1D
Type 1 Diabetes MellitusType 1 Diabetes (T1D)
GentiBio, Inc16 enrolled10 locationsNCT06919354
Recruiting
Long Term Surveillance of Islet Transplant Recipients Following Complete Graft Loss
Type 1 Diabetes Mellitus
Rodolfo Alejandro60 enrolled1 locationNCT02000687
Recruiting
Not Applicable
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
Type 1 Diabetes Mellitus
Rodolfo Alejandro18 enrolled1 locationNCT01999361
Recruiting
Long Term Follow up of Recipients of Functional Islet Allografts
Type 1 Diabetes Mellitus
Rodolfo Alejandro30 enrolled1 locationNCT01999374
Recruiting
Phase 1Phase 2
A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes
Type 1 DiabetesNew Onset
City of Hope Medical Center120 enrolled11 locationsNCT07061574
Recruiting
Phase 1Phase 2
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
Type 1 DiabetesType 1 Diabetes MellitusType 1 Diabetes Mellitis+7 more
COUR Pharmaceutical Development Company, Inc.72 enrolled31 locationsNCT06783309
Recruiting
Phase 1Phase 2
Safety and Efficacy of CELZ-201 in Patients With Recent Onset Type 1 Diabetes
Diabetes Mellitus, Type 1Type 1 Diabetes
Creative Medical Technology Holdings Inc18 enrolled1 locationNCT05626712
Recruiting
Phase 2
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
Type 1 Diabetes
SAb Biotherapeutics, Inc.159 enrolled65 locationsNCT07187531